Credit score: Kuzmik_A \/ iStock \/ Getty Photos Plus<\/figcaption><\/figure>\n<\/div>\nResearchers on the College of Maryland Faculty of Drugs\u2019s Middle for Vaccine Improvement and World Well being (CVD) reported encouraging interim outcomes from an early scientific trial that examined a brand new twin vaccine towards Lassa fever and rabies. The examine discovered the vaccine to be secure and induced immune responses towards each the Lassa fever and rabies viruses (RB). There are presently no vaccines towards Lassa fever available on the market.<\/p>\n
\u201cThis vaccine is designed to guard towards two viruses of worldwide well being significance,\u201d stated examine principal investigator Justin Ortiz, MD, MS, professor of medication at UMSOM and vaccine researcher at CVD. \u201cBy combining targets right into a single product, it might scale back the necessity for separate vaccination efforts and streamline supply in settings the place entry is restricted.\u201d<\/p>\n
Ortiz is first and corresponding writer of the researchers\u2019 revealed paper in Nature Drugs, titled \u201cAdjuvanted inactivated rabies virus-vectored Lassa virus vaccine in wholesome adults: a part 1 trial,\u201d by which they stated, \u201cIf efficacy is confirmed, this mixture vaccine might assist shield populations from two precedence pathogens and have a significant public well being impression in areas the place each illnesses stay main threats.\u201d<\/p>\n
The World Well being Group has recognized Lassa virus (LASV) as a public well being risk in western Africa and made Lassa fever a precedence illness for analysis. \u201cTransmission happens primarily by way of contact with meals or home items contaminated by urine or feces from Mastomys rodents, though person-to-person unfold can happen through publicity to bodily fluids or contaminated surfaces,\u201d the investigators famous of their paper. Like Ebola, Lassa virus can set off extreme sickness and periodic outbreaks in African nations.<\/p>\n
Lassa virus infections happen in 300,000 individuals yearly leading to 5,000 deaths, in accordance with figures cited by the authors, however these numbers are probably an underestimate as a consequence of restricted surveillance. The illness is especially harmful in being pregnant with over 80% of late-term infections leading to deaths to the mom or fetus. Moreover, areas the place Lassa fever is frequent, such elements of Western and Sub-Saharan Africa, even have a excessive burden of rabies, with 1000’s of deaths yearly, a illness that’s nearly at all times deadly as soon as signs develop. The newly reported first-in-human trial was designed to guage the security and immunogenicity of an adjuvanted inactivated rabies virus expressing the Lassa virus glycoprotein advanced (GPC) on the floor of the virus. \u201cScientists at Thomas Jefferson College developed an inactivated rabies-vectored mixture vaccine derived from an attenuated rabies pressure, LASSARAB, expressing each the rabies glycoprotein and the LASV (Josiah pressure) GPC,\u201d the authors defined. \u201cThe RABV platform gives a well-established basis for a dual-target vaccine.\u201d<\/p>\n
For the randomized, managed trial 54 wholesome grownup volunteers from the Baltimore space had been randomly assigned to obtain completely different doses of LASSARAB, with an adjuvant or a licensed rabies vaccine management. Members obtained two vaccine doses 28 days aside. Immune responses had been studied by way of 61 days post-vaccination for an interim evaluation. The outcomes point out that LASSARAB was secure with no severe opposed occasions (AEs) reported after vaccination. Moreover, the candidate vaccine induced speedy and sturdy antibody responses towards each Lassa and rabies viruses when put next with the management, which solely induced an immune response towards rabies virus.<\/p>\n
The examine is ongoing, and vaccine security and immune responses will probably be additional studied by way of 394 days post-vaccination.\u00a0\u201cThe ultimate examine report will probably be ready after examine completion and can embrace severe AEs and AEs of particular curiosity by way of day 394, protocol-defined exploratory LASV and RABV antibody responses assessed at days 121 and 394, and any further put up hoc analyses, as relevant,\u201d the staff acknowledged.<\/p>\n
If the outcomes point out continued elevated immune responses from vaccination, researchers will proceed with extra superior scientific trials. Importantly, this investigational vaccine could be freeze-dried for storage, enabling distribution to areas of the world the place it could be troublesome to take care of chilly chains. Importantly, this investigational vaccine could be freeze-dried for storage, enabling distribution to areas of the world the place it could be troublesome to take care of chilly chains.<\/p>\n
\u201cThese information help the feasibility of a bivalent rabies-vectored vaccine built-in into routine immunization for areas the place cold-chain capability is restricted,\u201d the staff added.<\/p>\n
\u201cThis examine highlights CVD\u2019s dedication to tackling illnesses of worldwide significance,\u201d commented Stefan Kappe, PhD, director of the Middle for Vaccine Improvement and World Well being and the Myron M. Levine Endowed Professor of Pediatrics. \u201cLASSARAB not solely targets illnesses of concern however makes use of a platform that might make distribution attainable within the areas of the world which can be most affected by these illnesses.\u201d<\/p>\n
Added UMSOM dean Mark T. Gladwin, MD, \u201cLocal weather change is inflicting Lassa fever to increase its attain far past its Nigerian and West African origins, placing an estimated 700 million individuals in danger worldwide. By 2070, the variety of international locations throughout Africa that may develop ecological situations appropriate for Lassa virus unfold might drastically enhance, so a vaccine to forestall this lethal an infection is desperately wanted.\u201d<\/p>\n
Final 12 months, earlier than outcomes had been accessible, the trial was highlighted by\u00a0Nature Drugs\u00a0in its 2025 characteristic, \u201cEleven scientific trials that may form drugs in 2026,\u201d which recognized research to look at based mostly on their potential to deal with main unmet well being wants.<\/p>\n<\/p><\/div>\n
\n
Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Credit score: Kuzmik_A \/ iStock \/ Getty Photos Plus Researchers on the College of Maryland Faculty of Drugs\u2019s Middle for Vaccine Improvement and World Well being (CVD) reported encouraging interim outcomes from an early scientific trial that examined a brand new twin vaccine towards Lassa fever and rabies. The examine discovered the vaccine to be […]<\/p>\n","protected":false},"author":1,"featured_media":779,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2025\/04\/GettyImages-13044998711.jpg","fifu_image_alt":"","jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_override_bookmark_settings":[],"jnews_social_meta":[],"jnews_override_counter":[],"footnotes":""},"categories":[10],"tags":[160,1089,1086,1090,1088,636,1087,1091],"class_list":["post-777","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","tag-data","tag-dual","tag-firstinhuman","tag-lassarabies","tag-promising","tag-reports","tag-trial","tag-vaccine"],"yoast_head":"\n
First-in-Human Trial Experiences Promising Twin Lassa\u2013Rabies Vaccine Knowledge - Future News 24<\/title>\n<meta name=\"description\" content=\"Interim trial results showed vaccine to be safe and induced immune responses against Lassa virus and rabies virus.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First-in-Human Trial Experiences Promising Twin Lassa\u2013Rabies Vaccine Knowledge - Future News 24\" \/>\n<meta property=\"og:description\" content=\"Interim trial results showed vaccine to be safe and induced immune responses against Lassa virus and rabies virus.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/\" \/>\n<meta property=\"og:site_name\" content=\"Future News 24\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-09T19:48:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-09T21:59:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.genengnews.com\/wp-content\/uploads\/2025\/04\/GettyImages-13044998711.jpg\" \/>\n<meta name=\"author\" content=\"Future News 24\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.genengnews.com\/wp-content\/uploads\/2025\/04\/GettyImages-13044998711.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Future News 24\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/09\\\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/09\\\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\\\/\"},\"author\":{\"name\":\"Future News 24\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\"},\"headline\":\"First-in-Human Trial Experiences Promising Twin Lassa\u2013Rabies Vaccine Knowledge\",\"datePublished\":\"2026-06-09T19:48:00+00:00\",\"dateModified\":\"2026-06-09T21:59:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/09\\\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\\\/\"},\"wordCount\":917,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/09\\\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.genengnews.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/GettyImages-13044998711.jpg\",\"keywords\":[\"data\",\"Dual\",\"FirstinHuman\",\"LassaRabies\",\"Promising\",\"reports\",\"Trial\",\"Vaccine\"],\"articleSection\":[\"BioTechnology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/09\\\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/09\\\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/09\\\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\\\/\",\"name\":\"First-in-Human Trial Experiences Promising Twin Lassa\u2013Rabies Vaccine Knowledge - Future News 24\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/09\\\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/09\\\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.genengnews.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/GettyImages-13044998711.jpg\",\"datePublished\":\"2026-06-09T19:48:00+00:00\",\"dateModified\":\"2026-06-09T21:59:25+00:00\",\"description\":\"Interim trial results showed vaccine to be safe and induced immune responses against Lassa virus and rabies virus.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/09\\\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/09\\\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/09\\\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.genengnews.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/GettyImages-13044998711.jpg\",\"contentUrl\":\"https:\\\/\\\/www.genengnews.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/GettyImages-13044998711.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/09\\\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/futurenews24.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First-in-Human Trial Experiences Promising Twin Lassa\u2013Rabies Vaccine Knowledge\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"name\":\"Future News 24\",\"description\":\"The Smart Hub for AI and Next-Gen Innovation\",\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/futurenews24.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\",\"name\":\"Future News 24\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"contentUrl\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"width\":250,\"height\":250,\"caption\":\"Future News 24\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\",\"name\":\"Future News 24\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"caption\":\"Future News 24\"},\"sameAs\":[\"https:\\\/\\\/futurenews24.com\"],\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/author\\\/mridulpahuja20\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First-in-Human Trial Experiences Promising Twin Lassa\u2013Rabies Vaccine Knowledge - Future News 24","description":"Interim trial results showed vaccine to be safe and induced immune responses against Lassa virus and rabies virus.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/","og_locale":"en_US","og_type":"article","og_title":"First-in-Human Trial Experiences Promising Twin Lassa\u2013Rabies Vaccine Knowledge - Future News 24","og_description":"Interim trial results showed vaccine to be safe and induced immune responses against Lassa virus and rabies virus.","og_url":"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/","og_site_name":"Future News 24","article_published_time":"2026-06-09T19:48:00+00:00","article_modified_time":"2026-06-09T21:59:25+00:00","og_image":[{"url":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2025\/04\/GettyImages-13044998711.jpg","type":"","width":"","height":""}],"author":"Future News 24","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2025\/04\/GettyImages-13044998711.jpg","twitter_misc":{"Written by":"Future News 24","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/#article","isPartOf":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/"},"author":{"name":"Future News 24","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83"},"headline":"First-in-Human Trial Experiences Promising Twin Lassa\u2013Rabies Vaccine Knowledge","datePublished":"2026-06-09T19:48:00+00:00","dateModified":"2026-06-09T21:59:25+00:00","mainEntityOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/"},"wordCount":917,"commentCount":0,"publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/#primaryimage"},"thumbnailUrl":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2025\/04\/GettyImages-13044998711.jpg","keywords":["data","Dual","FirstinHuman","LassaRabies","Promising","reports","Trial","Vaccine"],"articleSection":["BioTechnology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/","url":"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/","name":"First-in-Human Trial Experiences Promising Twin Lassa\u2013Rabies Vaccine Knowledge - Future News 24","isPartOf":{"@id":"https:\/\/futurenews24.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/#primaryimage"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/#primaryimage"},"thumbnailUrl":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2025\/04\/GettyImages-13044998711.jpg","datePublished":"2026-06-09T19:48:00+00:00","dateModified":"2026-06-09T21:59:25+00:00","description":"Interim trial results showed vaccine to be safe and induced immune responses against Lassa virus and rabies virus.","breadcrumb":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/#primaryimage","url":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2025\/04\/GettyImages-13044998711.jpg","contentUrl":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2025\/04\/GettyImages-13044998711.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/09\/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/futurenews24.com\/"},{"@type":"ListItem","position":2,"name":"First-in-Human Trial Experiences Promising Twin Lassa\u2013Rabies Vaccine Knowledge"}]},{"@type":"WebSite","@id":"https:\/\/futurenews24.com\/#website","url":"https:\/\/futurenews24.com\/","name":"Future News 24","description":"The Smart Hub for AI and Next-Gen Innovation","publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/futurenews24.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/futurenews24.com\/#organization","name":"Future News 24","url":"https:\/\/futurenews24.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/","url":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","contentUrl":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","width":250,"height":250,"caption":"Future News 24"},"image":{"@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83","name":"Future News 24","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","caption":"Future News 24"},"sameAs":["https:\/\/futurenews24.com"],"url":"https:\/\/futurenews24.com\/index.php\/author\/mridulpahuja20\/"}]}},"_links":{"self":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/comments?post=777"}],"version-history":[{"count":1,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/777\/revisions"}],"predecessor-version":[{"id":778,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/777\/revisions\/778"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media\/779"}],"wp:attachment":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media?parent=777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/categories?post=777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/tags?post=777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Medical](\"https:\/\/www.genengnews.com\/wp-content\/uploads\/2025\/04\/GettyImages-13044998711-696x464.jpg\" "\\"Medical")